Last reviewed · How we verify

NCT06863337

Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring

Recruiting now NA Last updated 23 December 2025
What this trial tests

NA trial testing CGM in Infertility Female in 100 participants. Currently enrolling.

Timeline
26 March 2025
Primary endpoint
30 June 2026
30 April 2027

Quick facts

Lead sponsorShanghai 6th People's Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment100
Start date26 March 2025
Primary completion30 June 2026
Estimated completion30 April 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai 6th People's Hospital

Who can join

Adults 18 to 40, female only, with Infertility Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

No studies have been seen on glucose variation during medication for assisted reproduction. The aim of this study is to continuously observe glucose variation during assisted reproduction treatment using continuous glucose monitoring (CGM), and to further explore whether glucose variation will affect the outcomes related to assisted reproduction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CGM

Trials testing the same drug.

Other recruiting trials for Infertility Female

Currently open trials in the same condition.

Other Shanghai 6th People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06863337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing